Sahadain, Julimar S.
HRN: 23-08-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/15/2023
06/21/2023
IV
150mg
OD
Septic Shock Sec To Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes